Perbedaan Harga & Kinerja Alkindo Naratama Tbk (ALDO) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga
Pergerakan harga dalam 24 jam terakhir
Statistik utama
Statistik utama
Perbedaan Alkindo Naratama Tbk dan Brigit Biofarmaka Teknologi Tbk.: Alkindo Naratama Tbk diperdagangkan di Rp690 (kapitalisasi pasar 1,89 T, volume 24 jam 1,7 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 160,57 M, volume 24 jam 2,51 jt). Perbedaan utamanya: Alkindo Naratama Tbk jauh lebih besar — sekitar 11,8× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (2,51 jt vs 1,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ALDO | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 1,89 T | 160,57 M |
Volume | 1,7 rb | 2,51 jt |
Lot | 17 | 25,09 rb |
Perputaran | 1,17 jt | 636,74 jt |
Harga Rata-rata | 688,24 | 253,78 |
Nilai Transaksi | 1,17 jt | 636,74 jt |
Harga Ekuilibrium Indikatif | 690 | 242 |
Volume Ekuilibrium Indikatif | 1 | 146 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Alkindo Naratama Tbk
PT Alkindo Naratama Tbk (the "Company") was established based on Notarial Deed No 74 of Kikit Warianti SH, dated January 31, 1989. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 5 of Nunuy Rahmayati SH dated March 15, 2011 pertaining of Authorized share and paid-up capital, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity
Selengkapnya di halaman ALDO →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
